SHS Capital takes majority stake in ESSERT

• ESSERT is the fourth transaction from SHS VI fund generation
• SHS Capital is a private equity firm that invests in healthcare companies in Europe
• The firm is based in Tübingen, Germany

SHS Capital has acquired a majority stake in ESSERT, a life science robotics company. No financial details of the transaction were disclosed.

ESSERT is based in Bruchsal, Germany. The company develops automation products for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors.

ESSERT is the fourth transaction from SHS VI fund generation, launched in 2022.

“ESSERT is a prime example of the focus of our newly launched SHS VI fund generation,” said Cornelius Maas, SHS partner. “As an established, medium-sized company that anticipated the challenges of tomorrow’s production in the pharmaceutical and life science sectors early on, it perfectly addresses the current trend in the industry and has the opportunity to establish itself as a European market leader.”

SHS Capital is a private equity firm that invests in healthcare companies in Europe. The firm is currently investing from its sixth fund and has a volume of around €270 million. It is based in Tübingen, Germany.